Clinical Trials Browser

Phase 2 × OTHER × merestinib × Clear all

NCT02920996 2024-04-11

Merestinib In Non-Small Cell Lung Cancer And Solid Tumors

Phase 2 Terminated

12 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung